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Abstract: Scaffolds are crucial to tissue engineering/re-
generation. In this work, a technique combining a unique
phase-separation process with a novel sugar sphere tem-
plate leaching process has been developed to produce three-
dimensional scaffolds. The resulting scaffolds possess high
porosities, well connected macropores, and nanofibrous
pore walls. The technique advantageously controls macro-
pore shape and size by sugar spheres, interpore opening size
by assembly conditions (time and temperature of heat treat-
ment), and pore wall morphology by phase-separation pa-
rameters. The bioactivity of a macroporous and nanofibrous
poly(l-lactic acid) (PLLA) scaffold was demonstrated by the
bone-like apatite deposition throughout the scaffold in a
simulated body fluid (SBF). Preincorporation of nanosized
hydroxyapatite eliminated the induction period and facili-
tated the apatite growth in the SBF. Interestingly, the apatite
growth primarily occurred on the surface of the pores (in-
ternal and external) but not the interior of the nanofibrous
network away from the pore surface. It was also noticed that
the macropore size did not affect the apatite growth rate,
while the interpore opening size did. The compressive mod-
ulus also increased substantially when a continuous apatite
layer was formed on the pore walls of the scaffold. The
resulting composite scaffold mimics natural bone matrix
with the combination of an organic phase (a polymer such as
PLLA) and an inorganic apatite phase. The demonstrated
bioactivity of apatite layer, together with well-controlled
macroporous and nanofibrous structures, makes the novel
nanocomposite scaffolds desirable for bone tissue engineer-
ing. © 2006 Wiley Periodicals, Inc. J Biomed Mater Res 78A:
306–315, 2006
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INTRODUCTION
Strategies for bone tissue engineering are generally
based on either the implantation of a porous scaffold
to harness the natural progression of osseous growth
or the seeding of osteogenic cells onto a three-dimen-
sional (3D) scaffold followed by in vivo implantation to
repair bone defects. In both cases, the scaffold serves
as a temporary physical support and template for
initial cell attachment, and it provides a microenviron-
ment appropriate for further osteogenesis.1,2 The de-
velopment of appropriate 3D scaffolds for the main-
tenance of cellular viability and phenotype is critical
and has been a challenge in the field of tissue engi-
neering.3–6 Scaffold materials must meet certain phys-
ical and biological criteria for tissue engineering ap-
plications. In terms of physical properties, an ideal
scaffold should have three-dimensionally well-con-
nected macropore structure to accommodate cells and
to facilitate cell migration, proliferation, and differen-
tiation, thereby ensuring functional neotissue forma-
tion. Consequently, scaffolds with high porosity and
interconnected pore structures generally favor tissue
regeneration.7,8
The surface morphology has been demonstrated to
play a significant role in regulating cell activities such
as attachment, proliferation, and/or differentiation.9,10
Polymeric scaffolds with a nanofibrous pore wall ar-
chitecture improved initial osteoblastic cell attach-
ment (24 h) as compared to those with relatively
smooth pore walls, possibly due to the selective ad-
sorption of fibronectin and vitronectin on a nanofi-
brous scaffold.9
In previous studies, we used paraffin spheres to
fabricate porous scaffolds. The main advantage of us-
ing paraffin spheres as a porogen (pore-generating
material) is that, unlike other porogens (such as so-
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dium chloride crystals), they can be heat treated to
form a bound template, thus creating interconnected
pore openings in the final scaffolds. However, there
are also some disadvantages of using paraffin spheres
because many organic solvents such as tetrahydrofu-
ran (THF), dioxane, dichloromethane, and pyridine
Figure 1. Fabrication process of sugar sphere template leaching and thermally induced phase separation technique, shown
by SEM micrographs: (a) sugar particles as received (250–425 m); (b) sugar spheres (250–425 m) prepared via emulsion
technique; (c) sugar sphere template after heat treatment at 37°C for 15 min; (d) polymer/sugar composite after polymer
casting, phase separation, solvent exchange, and freeze-drying; (e, f) 3D macroporous and nanofibrous scaffold at low (50)
and high (10,000) magnifications.
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used for polymer dissolution also have varying de-
grees of solubility to paraffin. Therefore, paraffin
spheres are not an ideal porogen for these systems. In
addition, trace amount of paraffin could be left in the
scaffolds, which could be unfavorable for the subse-
quent cell activity due to its hydrophobicity. In this
work, we developed alternative sugar spheres to pre-
pare 3D macroporous and nanofibrous scaffolds. Such
scaffolds retained the advantages of interconnected
spherical pores while avoiding the use of paraffin.
Sugar is water soluble, allows removal without using
organic solvents, and is suitable for the fabrication of
scaffolds from any water insoluble polymers.
Because hydroxyapatite (HAP) is the major mineral
phase in natural bone, coating a thin layer of HAP
onto a metallic or polymeric material surface has been
utilized to induce faster biological fixation of implants
to host bone tissue.11,12 For bone tissue engineering,
the scaffold should also provide desired osteoconduc-
tivity13,14 and mechanical properties.15–17 The bioac-
tivity of the new scaffold was demonstrated using in
vitro bone-like apatite particle growth in a simulated
body fluid (SBF). The apatite growth on the nanofi-
brous scaffolds also improved the mechanical proper-
ties. Therefore, the resulting novel polymer/apatite
composite scaffolds should be advantageous for bone
tissue engineering.
MATERIALS AND METHODS
Poly(l-lactic acid) (PLLA) with an inherent viscosity of
1.4–1.8 dl/g was purchased from Boehringer Ingelheim (In-
gelheim, Germany) and was used as received. Hydroxyap-
atite nanocrystals (nHAP) were purchased from Berkeley
Advanced Biomaterials (San Leandro, CA). d-fructose (m.p.
119–122°C), mineral oil, and sorbitanmonooleate (Span 80)
Figure 2. SEM micrographs of 3D nanofibrous PLLA scaf-
folds with varying macropore sizes: (a) 180–250 m; (b)
425–600 m. The magnification is 50.
TABLE I















PLLA180a 180–250 37°C, 15 min. 97.8 71.2  13.1 22.4
PLLA250b 250–425 NT* 97.0 56.9  14.9 4.8
PLLA250 250–425 37°C, 15 min. 97.8 116.5  20.0 18.9
PLLA250 250–425 37°C, 30 min. 98.0 125.7  31.5 24.6
PLLA250 250–425 57°C, 15 min. 98.2 129.1  39.8 28.7
PLLA425c 425–600 NT* 96.9 75.0  14.1 3.9
PLLA425 425–600 37°C, 15 min. 97.7 157.8  39.3 22
PLLA425 425–600 37°C, 30 min. 97.8 165.4  28.7 24.9
PLLA/nHAP250d 250–425 37°C, 15 min. 97.5 106.3  16.7 17.6
aPLLA scaffold prepared using sugar spheres, 180–250 m in diameter.
bPLLA scaffold prepared using sugar spheres, 250–425 m in diameter.
cPLLA scaffold prepared using sugar spheres, 425–600 m in diameter.
dPLLA/nHAP composite scaffold prepared using sugar spheres, 250–425 m in diameter.
*NT—No heat treatment.
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were from Sigma (St. Louis, MO). Cyclohexane and hexane
were from Fisher Scientific (Pittsburgh, PA). THF and all
other chemicals were from Aldrich Chemical Company
(Milwaukee, WI).
Preparation of sugar spheres
Sugar spheres with different sizes were prepared by an
emulsion technique. Typically, 50 g of d-fructose were
melted at 120°C for 90 min until clear yellowish liquid was
obtained. The liquefied sugar was emulsified into 50 mL
mineral oil with 1.3 mL Span 80 at 120°C under stirring. The
resulting mixture was cooled down using an ice-bath to
solidify sugar spheres. After discarding the mineral oil, the
sugar spheres were washed with hexane three times and
sieved to select desired sizes (180–250, 250–425, and 425–
600 m size ranges). The sieved sugar spheres were packed
in a Teflon vial with hexane and heat treated for a certain
time period to form a sugar sphere template. After bonding
the sugar spheres, hexane was removed, and the sugar
template was dried under vacuum.
Polymer casting and phase separation
The phase separation procedure for fabrication of porous
scaffold was modified from Ma and Zhang.4,18 Briefly, about
0.6–0.8 mL 10% PLLA/THF solution or PLLA/nHAP/THF
suspension was cast into the assembled sugar template.
Mild vacuum was applied during casting in order to fully fill
the interspaces of the bonded sugar template with polymer
solution. The polymer solution/sugar template was phase
separated at 20°C overnight and then immersed into cy-
clohexane to extract solvent (THF) for 2 days. The resulting
composites were freeze-dried. The sugar template was then
leached away in distilled water, and the highly porous nano-
fibrous scaffold was freeze-dried.
Bone-like apatite deposition
Prefabricated nanofibrous scaffolds were incubated in a
1.5 SBF with a modified formulation that was prepared by
dissolving NaCl, NaHCO3, KCl, K2HPO43H2O, MgCl26H2O,
Figure 3. SEM micrographs of 3D nanofibrous PLLA scaffolds with varying interpore opening ratios (IOR) under different
assembling conditions: (a) without heat treatment (4.8%); (b) 37°C for 15 min (18.9%); (c) 37°C for 30 min (24%); (d) 57°C for
15 min (29.1%).
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CaCl2, and Na2SO4 in deionized water and buffered at a pH
value of 7.4 at 37°C with tri-(hydroxymethyl) aminomethane
[(CH2OH)3CNH2] and hydrochloric acid (HCl). The inor-
ganic ion concentrations (Na 213, K 7.5, Mg2 2.3, Ca2
3.8, Cl 223, HCO3
 27, HPO4
2 1.5, and SO4
2 0.8 mM)
were 1.5 times those of human blood plasma. The SBF
solution was changed every other day. After incubation at
37°C for a designated time period, scaffolds were removed
from SBF, rinsed with distilled water twice overnight, and
vacuum dried.
Morphological characterization
The porous morphologies of the scaffolds were examined
with scanning electron microscopy (SEM) (Hitachi S-3200N
and Philips XL30 FEG) at 15–20 kV. The samples were cut by
a razor blade or fractured after liquid nitrogen treatment
and coated with gold for 150 s using a sputter coater (Desk-
II, Denton Vacuum). Overall porosity was calculated using
the method described by Wei and Ma.15 Interpore opening
size and interpore opening ratio (IOR) were determined
from SEM images according to Chen and Ma.19 IOR is
defined as the ratio of interpore opening area to macropore
surface area in a scaffold. At least 30 pores in a few repre-
sentative SEM images were analyzed. For energy-dispersive
spectroscopy (EDS), scaffold samples without gold coating
were used to characterize the composition of apatite parti-
cles under an environmental mode.
Surface area measurement
The specific surface area (ABET) measurement was per-
formed on nanofibrous PLLA scaffolds using a BELSORP-
mini apparatus (BEL Japan). Adsorption/desorption iso-
therms of samples were obtained using nitrogen as the
adsorbate and liquid nitrogen as cooling medium. Surface
area of nanofibrous scaffolds was calculated from Brunauer–
Emmett–Teller (BET) plot of adsorption/desorption iso-
therm using adsorption points in the P/P0 range of 0.1–0.3
(BELSORP-mini analysis software).
Mechanical test
The compressive mechanical properties of the scaffolds
were measured using a MTS Synergie 200 mechanical tester
(MTS systems, Eden Prairie, Minnesota). Scaffolds with di-
mensions of 17.5  0.5 mm in diameter and 3 mm in thick-
ness were used. Five specimens were tested for each sample.
The compressive modulus was defined as the initial linear
modulus on the stress–strain curves. A two-tail Student’s
t-test (unequal variances) was performed to determine the




Macroporous and nanofibrous scaffolds have been
prepared using sugar template leaching and phase-
separation techniques following the steps depicted in
Figure 1(a–d). Figure 1(e,f) show the typical morphol-
ogy of scaffolds prepared using sugar spheres with a
diameter of 250–425 m (PLLA250) and heat treated
at 37°C for 15 min. The scaffold has macropores 250–
425 m in diameter, an average interpore opening size
of 116 m, and nanofibers with an average diameter in
the order of 100 nm. By varying sugar sphere size and
assembly conditions (heat treatment temperature and
time), one can easily control the macropore size, the
interpore opening size, and interpore opening area
ratio (Table 1). Figure 2 shows the morphology of
scaffolds with different macropore sizes. Under the
same assembly conditions (37°C for 15 min), the re-
sulting scaffolds have the same high porosity of 98%
despite the differences in macropore size. With the
same IOR of about 20%, the average interpore opening
sizes are substantially different, varying from 71 m
Figure 4. Effect of (a) macropore size and (b) interpore
opening ratio on mechanical properties of the scaffold.
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Figure 5. SEM micrographs of nanofibrous PLLA scaffolds incubated in 1.5 SBF for varying times: (a, b) 4 days (at low and
high magnifications); (c) 6 days; (d) 8 days; (e, f) 22 days, and (g, h) 30 days.
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for scaffolds prepared with 180–250 m sugar spheres
to 158 m for scaffolds prepared with 425–600 m
sugar spheres. The IOR is controlled by the sugar
sphere assembling conditions, mainly the heat treat-
ment temperature and time (Fig. 3). The IORs of 4.8%
and 29.1% are achieved for PLLA scaffolds without
heat treatment and with heat treatment at 57°C for 15
min, respectively (Table 1).
Macroporous and nanofibrous PLLA scaffold has a
very high surface area of 90–110 m2/g, regardless of
the macropore sizes and IORs. The nanofibrous struc-
ture contributes substantially to the large surface area
of the scaffold because the nonnano-fibrous equivalent
(scaffold with similar macroporous structure but with-
out nanofibrous networks) has a surface area lower
than 0.1 m2/g (data not shown).
Mechanical properties
For the measurement of mechanical properties, all
nanofibrous PLLA scaffolds have a similar porosity of
about 98%. The mechanical properties are examined
against macropore size [Fig. 4(a)] and IOR of the scaf-
folds [Fig. 4(b)]. The difference in compressive mod-
ulus between scaffolds with different macropore sizes
is not statistically significant (p  0.05), although scaf-
folds with smaller macropore size (180–250 m) show
a slightly higher compressive modulus than scaffolds
with larger macropore sizes (250–425 m or 425–600
m) [Fig. 4(a)]. A larger IOR results in a lower com-
pressive modulus [Fig. 4(b)].
Growth of bone-like apatite
In vitro growth of bone-like apatite particles on scaf-
folds is evaluated using SEM, EDS, mechanical prop-
Figure 6. Effect of interpore opening ratio (IOR) on apatite
formation on the scaffolds in the SBF. Macropore sizes of the
scaffolds: (a) 250–425 m and (b) 425–600 m. *p  0.05.
Legends in figures indicate the IOR of the scaffold.
Figure 7. Compressive modulus of the scaffolds after in-
cubation in SBF for varying times. *p  0.05 versus control
scaffold (before incubation).
Figure 8. Mass increase of nanofibrous PLLA and PLLA/
nHAP scaffolds over incubation time in 1.5 SBF.
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erties, and mass increase as a function of incubation
time. Figure 5 shows SEM micrographs of apatite
growth on PLLA nanofibrous scaffolds after varying
times of incubation in SBF. Substantial amounts of
bone-like apatite crystals are formed on nanofibrous
PLLA scaffolds after 6 days of incubation in SBF [Fig.
5(c)]. The deposited apatite particles grow into a few
hundred nanometers in size and have nanostructured
surface features. The underlying nanofibers become
hardly observable after 15 days of incubation. Further
incubation in the SBF leads to a continuous apatite
layer formation, covering all inner pore wall surfaces
[Fig. 5(e–h)]. The interconnected macroporous struc-
ture of the scaffolds is maintained, which is important
for cell migration and mass transport when used for
tissue regeneration. There is not appreciable apatite
formation in the bulk of nanofiber network away from
macropore wall surfaces [Fig. 5(g)]. The macropore
size (from 180–250 m, 250–425 m to 425–600 m)
of the scaffold does not have significant effect on the
rate and amount of apatite deposition (data not
shown). However, the interpore opening size and IOR
affect the apatite growth on scaffolds at long incuba-
tion times. Scaffolds with larger interpore openings
(158 m) and higher IOR (24%) allow significantly
more apatite deposition than those with smaller inter-
pore openings (58 m) and lower IOR (4%) (Fig. 6).
Significantly higher compressive modulus is observed
for composite scaffold when apatite particles become a
continuous layer covering the entire pore wall sur-
faces after 15 days or longer incubation times in SBF
(Fig. 7).
Preincorporation of nHAP particles in polymer scaf-
folds (even at a low content of 10 w/w%) induces
greater amounts of apatite formation in SBF as com-
pared to pure polymer scaffolds (Fig. 8). Substantial
amounts of apatite crystals are grown on PLLA/
nHAP composite scaffolds after 4 days of incubation
in SBF [Fig. 9(a,b)]. At this time, there is a negligible
amount of apatite formation on pure polymer scaf-
folds [Fig. 5(a,b)]. This is also confirmed by EDS spec-
tra (Fig. 10). There are significant increases of Ca and
Figure 9. SEM micrographs of nanofibrous PLLA/nHAP (90:10) composite scaffolds incubated in 1.5 SBF for varying
times. (a, b) 4 days [(b) is a portion of (a) at a higher magnification in which the newly formed bone-like apatite is colored
green]; (c, d) 30 days. [Color figure can be viewed in the online issue, which is available at www.interscience.wiley.com.]
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P elements in the PLLA/nHAP (10 w/w% nHAP)
scaffolds after 4 days of incubation in the SBF. How-
ever, the Ca and P elements are not detectable for pure
PLLA scaffolds after 4 days of incubation in the SBF.
The size and morphology of apatite particles on
PLLA/nHAP nanocomposite scaffolds (Fig. 9) are dif-
ferent from those on pure PLLA scaffolds (Fig. 5). The
apatite particle size increases from 0.8–1 m at day 4
to 2–2.5 m at day 30 for PLLA/nHAP scaffolds while
the apatite particles on PLLA scaffolds are less than 1
m in diameter after 30 days of incubation.
DISCUSSION
To achieve the ultimate goal of tissue engineering,
generating clinically useful tissue and organ replace-
ment, great efforts have been made in scaffold designs
to regulate cell behavior including attachment, migra-
tion, proliferation, and differentiation on a scaffold.9,13
A tissue engineering scaffold should have high poros-
ity, suitable macropore size, well-controlled interpore
openings, appropriate surface morphologies, and suit-
able mechanical properties as well as bioactivity. Sev-
eral techniques have been developed to fabricate 3D
porous scaffolds.3,5,20 However, there is still a limited
capacity of controlling scaffold structural features and
functions. We have presented in this work, a phase
separation and sugar sphere leaching technique to
prepare highly porous 3D scaffold with good mechan-
ical properties, controlled pore geometries, and a
nanofibrous pore wall surface morphology. In this
scaffold system, macropores and interpore openings
are designed to facilitate initial cell seeding and mass
transfer during in vitro cell culture, and nanofibrous
pore wall structures for better cell attachment, prolif-
eration, and differentiation functions. The insufficient
interconnected macroporosity of certain scaffolds has
been shown to limit cell colonization to the very su-
perficial layer (240 m from surface of a 1.9 mm-
thick scaffold).6 The presence of interpore openings,
therefore, is considered to be essential for cellular
activities,2 including uniform cell seeding throughout
the scaffold in vitro and angiogenesis in vivo. The
newly developed technique can be employed to fab-
ricate a variety of polymers into 3D scaffolds with a
high porosity and well-controlled macropores and in-
terpore openings.
An attractive feature of the technique is that nano-
fibrous structure has been incorporated into macro-
pore walls of the 3D PLLA scaffolds [Fig. 1(f)]. The
density of the nanofibers can be modulated by phase-
separation parameters such as polymer solution con-
centration and phase-separation temperature. The
nanofibrous structure, which mimics the main natural
bone extracellular matrix (ECM) component (collagen)
in size, has been demonstrated to improve cell attach-
ment9 and proliferation.21 The combination of inter-
connected macroporous and nanofibrous features in a
3D scaffold would provide a better environment for
cell growth and differentiation.
To be effectively used for bone tissue regeneration,
it is beneficial that a scaffold promotes bone-like apa-
tite formation when in contact with physiological
fluid. To evaluate the bioactivity of the novel macro-
porous and nanofibrous PLLA scaffolds developed in
this study, we have investigated their ability to form
bone-like apatite in a SBF. Apatite particles were de-
posited uniformly throughout the macroporous and
nanofibrous PLLA scaffolds. With increasing incuba-
tion time, the density of the apatite layer increased.
Noting very uniform growth of apatite layers through-
out the macroporous and nanofibrous PLLA scaffolds
but not on the scaffolds without the nanofeatures,16,22
it is likely that the physical and surface characteristics
Figure 10. EDS spectra of apatite deposited on (a) PLLA
and (b) PLLA/nHAP scaffolds. The peak of carbon element
in each curve was normalized to 100 counts/s.
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of the scaffold (macropores, interpore openings, and
nanotopography) affect the formation kinetics and
morphology of apatite layers.22 The preincorporation
of nHAP greatly altered the apatite growth profile; it
eliminated an induction time for stable nuclei forma-
tion and accelerated apatite growth. It also led to
greater mass increase and larger apatite particle size,
which may be attributed to the increased ionic avail-
ability, possibly due to the lower number of nuclei
(preincorporated nHAP) in PLLA/nHAP scaffolds.
Plasma spraying process, a most commonly used
conventional HAP-coating technique,23 is not appro-
priate for biodegradable 3D scaffold because of heat
generation during the process and its inability to cover
the entire surfaces of the deep internal pores because
of the nature of the process. Furthermore, possible
overcoating on the surface of the porous structure
with HAP generally alters the morphology of the
pores by blocking the macropores and interpore open-
ings. In this study, we have developed two different
methods to fabricate nanofibrous PLLA/nHAP (direct
mixing) or PLLA/apatite (biomimetic coating from
SBF) nanocomposite scaffolds. The biomimetic
method created a macroporous PLLA/apatite nano-
composite scaffold with preserved open macroporous
structure and improved mechanical properties. In ad-
dition, the biomimetic PLLA/apatite nanocomposite
scaffold provides an environment that mimics the nat-
ural bone matrix more closely (with polymer nanofi-
bers and apatite nanocrystals) and may enhance bone
tissue regeneration.
CONCLUSIONS
Macroporous and nanofibrous PLLA scaffolds are
prepared by a novel phase separation and sugar
sphere template leaching technique. The combined
technique has shown great control over macropore
size, interpore opening size, as well as pore wall mor-
phologies of 3D scaffolds. Bone-like apatite layer has
grown uniformly throughout 3D nanofibrous scaffold
after SBF incubation, which has not only demon-
strated the bioactivity of the macroporous and nano-
fibrous scaffold but has also provided a method to
generate biomimetic surfaces. The resulting scaffolds
should have better osteoconductivity and improved
mechanical properties for bone tissue engineering ap-
plications.
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